Stocktoria
Bone Biologics Corp BBLG
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-11-27
Bone Biologics Corp financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B |
| R&D expense | $1.1M | $2.1M | $6.9M | $1.6M | $82,044 | $340,672 | $1.1M | — | $104,490 | — |
| Operating income | -$3.2M | -$4.2M | -$9.4M | -$3.7M | -$1.1M | -$825,014 | -$2.4M | — | -$2.8M | — |
| Income tax | — | — | — | — | $1,600 | $1,600 | $1,603 | — | $1,729 | — |
| Net income | -$3.1M | -$4.1M | -$8.9M | -$1.5M | -$1.6M | -$1.8M | -$3.4M | — | -$4.4M | — |
| EPS (diluted) | $-2.65 | $-28.96 | $-34.01 | $-31.15 | — | — | — | — | — | — |
| Operating cash flow | -$2.7M | -$4.1M | -$9.6M | -$3.6M | -$1.2M | -$426,933 | -$3.3M | — | -$4.1M | — |
| Cash & equivalents | — | — | — | $7.5M | $6.7M | — | $24,145 | $726,407 | $955,374 | $2.3M |
| Total assets | $5.8M | $3.9M | $3.7M | $8.5M | $6.7M | $0 | $30,827 | $814,089 | $1.0M | $2.4M |
| Total liabilities | $418,587 | $377,712 | $831,402 | $2.5M | $99,909 | $13.7M | $11.9M | — | $9.6M | $9.5M |
| Shareholders' equity | $5.4M | $3.5M | $2.9M | $5.9M | $6.6M | -$13.7M | -$11.9M | -$10.0M | -$8.6M | -$7.2M |
Growth · year-over-year
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2019 | FY2018 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.